OncoAlert (@oncoalert) 's Twitter Profile
OncoAlert

@oncoalert

🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨

ID: 1109128247789395968

linkhttp://www.OncoAlert360.com calendar_today22-03-2019 16:22:35

95,95K Tweet

36,36K Followers

160 Following

OncoAlert (@oncoalert) 's Twitter Profile Photo
OncoAlert
@oncoalert

5 months ago

News Direct from Industry: "KEYNOTE 522 meets OS Endpoint in High Risk Early Stage TNBC #BreastCancer " "New OS results build on the pathological complete response and event-free survival data previously reported from the KEYNOTE-522 trial" " KEYNOTE522: Pembrolizumab in

News Direct from Industry: "KEYNOTE 522 meets OS Endpoint in High Risk Early Stage TNBC #BreastCancer " "New OS results build on the pathological complete response and event-free survival data previously reported from the KEYNOTE-522 trial" " KEYNOTE522: Pembrolizumab in